As important as Brilacidin is going to be I would
Post# of 72440
Allow an EUA to be issued immediately as those with moderate to severe cases recover and are able to leave the hospital should that become the norm for patients in the trial.
The above scenario takes care of those that need the drug NOW and also allows medicine to get a better handle on how B works in coronavirus patients (may even get some info that would help B be able to address the flu and other coronaviruses).
Anyways, that is how I would expect positive results to be handled.